Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.

Urologic oncology·2017
Same author

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer.

Urology case reports·2017
Same author

Diagnostic Accuracy of <sup>64</sup>Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.

Urology·2017
Same author

The Microbiome of the Prostate Tumor Microenvironment.

European urology·2017
Same author

Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.

Urologic oncology·2017
Same author

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.

Clinical genitourinary cancer·2017
Same journal

Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study.

The world journal of men's health·2026
Same journal

Spinal Contusion Injury-Induced Ejaculatory Dysfunction Is Reduced by Intrathecal Infusions of Gastrin Releasing Peptide in Male Rats.

The world journal of men's health·2026
Same journal

Plasma Metabolomic Signatures Linked to Healthy Lifestyle and Risk of Benign Prostatic Hyperplasia.

The world journal of men's health·2026
Same journal

Treating Erectile Dysfunction in Phosphodiesterase 5 Inhibitors Failures - Established Therapies and Newer Options.

The world journal of men's health·2026
Same journal

Dehydroepiandrosterone Sulfate/Cortisol Ratio as a Biomarker of Depressive Symptoms in Late-Onset Hypogonadism: An Analysis of 3,005 Males.

The world journal of men's health·2026
Same journal

Emerging Diagnosis and Treatment of Male Infertility: Hope versus Reality.

The world journal of men's health·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

Postprostatectomy Erectile Dysfunction: A Review.

Paolo Capogrosso1, Andrea Salonia1, Alberto Briganti1

  • 1Università Vita-Salute San Raffaele; Division of Experimental Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

The World Journal of Men'S Health
|August 31, 2016
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED) is a common issue after prostate cancer (PCa) surgery. Managing baseline factors and using treatments like PDE5 inhibitors can improve recovery of erectile function (EF).

Keywords:
Erectile dysfunctionPhosphodiesterase 5 inhibitorsProstatectomyProstatic neoplasmsRobotics

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.7K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 15, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.7K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.2K

Area of Science:

  • Urology
  • Oncology
  • Sexual Medicine

Background:

  • Erectile dysfunction (ED) affects up to 68% of patients post-radical prostatectomy (RP) for prostate cancer (PCa).
  • Effective management requires considering all factors influencing postoperative erectile function (EF) recovery.

Purpose of the Study:

  • To outline key factors and strategies for preventing and managing ED after RP.
  • To emphasize comprehensive patient assessment and tailored treatment approaches.

Main Methods:

  • Review of baseline patient characteristics (EF, age, comorbidities).
  • Evaluation of surgical techniques, including robotic RP and nerve-sparing approaches.
  • Assessment of pharmacotherapy (PDE5 inhibitors) and other treatment options for ED.

Main Results:

  • Baseline EF, age, and comorbidities significantly impact EF recovery post-RP.
  • Robotic RP may offer better EF outcomes compared to open techniques.
  • Oral phosphodiesterase 5 inhibitors (PDE5is) show promise for early tissue re-oxygenation and ED prevention.

Conclusions:

  • Preoperative assessment, patient counseling, and nerve-sparing techniques are crucial.
  • PDE5 inhibitors are a valuable first-line treatment post-RP.
  • Intracavernous therapies and penile prosthesis implantation are options for refractory ED.